Eli Lilly is a 'multi-diversified drugmaker', says Cantor Fitzgerald's Louise Chen
Published 2024-04-30Download video
Recommendations
-
02:32 Distinguished Purdue Alumni | Meet Dave Ricks: CEO of Eli Lilly
-
03:23 Don't Sleepwalk Through Life: Warren Buffett | CNBC
-
40:57 590. Can $55 Billion End the Opioid Epidemic? | Freakonomics Radio
-
09:14 Is 2024 a Good Time to Buy Eli Lilly or Novo Nordisk? | Intrinsic Valuation |
-
07:21 Why Eli Lilly is a top pick to capitalize on GLP-1 drug craze
-
26:26 About 50% Of Jobs Will Be Displaced By AI Within 3 Years
-
25:20 Ray Dalio’s Principles of Investing in a Changing World | WSJ News
-
05:35 Billionaire investor Ken Langone: Lilly will be the first trillion dollar drug company in history
-
30:33 Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine
-
13:23 Nvidia CEO Jensen Huang and the $2 trillion company powering today's AI | 60 Minutes
-
06:48 Eli Lilly (LLY) Hits High After Diabetes Drug Approval
-
04:23 Fundstrat's Tom Lee shares his thoughts on where the market goes from here...
-
13:58 What Is The BEST Healthcare Stock For MASSIVE Future GAINS?! | LLY And NVO Stock Analysis! |
-
15:37 JPMorgan CEO Jamie Dimon on Inflation, Markets, Fed, China, India
-
05:06 Eli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman
-
16:25 Jun Bei Liu on shorted stocks that are a good buy + Paul on how to create great income portfolios
-
03:58 Eli Lilly hits record high: Here's what investors need to know
-
32:47 NVIDIA’s Valuation and AI’s Negative Sum Game — with Aswath Damodaran | Prof G Markets
-
07:56 Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better
Similar videos